Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Elucidation of MRAS-mediated Noonan syndrome with cardiac hypertrophy
Erin M. Higgins, J. Martijn Bos, Heather Mason‐Suares, et al.
JCI Insight (2017) Vol. 2, Iss. 5
Open Access | Times Cited: 83

Showing 1-25 of 83 citing articles:

RAS Proteins and Their Regulators in Human Disease
Dhirendra K. Simanshu, Dwight V. Nissley, Frank McCormick
Cell (2017) Vol. 170, Iss. 1, pp. 17-33
Open Access | Times Cited: 1576
ERK: A Key Player in the Pathophysiology of Cardiac Hypertrophy
Simona Gallo, Annapia Vitacolonna, Alessandro Bonzano, et al.
International Journal of Molecular Sciences (2019) Vol. 20, Iss. 9, pp. 2164-2164
Open Access | Times Cited: 215
The RASopathy Family: Consequences of Germline Activation of the RAS/MAPK Pathway
Mylène Tajan, Romain Paccoud, Sophie Branka, et al.
Endocrine Reviews (2018) Vol. 39, Iss. 5, pp. 676-700
Open Access | Times Cited: 196
Genetics of Congenital Heart Disease
Kylia Williams, Jason Christopher Carson, Cecilia Lo
Biomolecules (2019) Vol. 9, Iss. 12, pp. 879-879
Open Access | Times Cited: 146
The RASopathies: from pathogenetics to therapeutics
Katie E. Hebron, Edjay R. Hernandez, Marielle E. Yohe
Disease Models & Mechanisms (2022) Vol. 15, Iss. 2
Open Access | Times Cited: 117
Single-nucleus chromatin accessibility profiling highlights regulatory mechanisms of coronary artery disease risk
Adam W. Turner, Shengen Hu, José Verdezoto Mosquera, et al.
Nature Genetics (2022) Vol. 54, Iss. 6, pp. 804-816
Open Access | Times Cited: 94
LZTR1 facilitates polyubiquitination and degradation of RAS-GTPases
Taiki Abe, Ikumi Umeki, Shin‐ichiro Kanno, et al.
Cell Death and Differentiation (2019) Vol. 27, Iss. 3, pp. 1023-1035
Open Access | Times Cited: 101
RIT1 oncoproteins escape LZTR1-mediated proteolysis
Pau Castel, Alice Cheng, Antonio Cuevas-Navarro, et al.
Science (2019) Vol. 363, Iss. 6432, pp. 1226-1230
Open Access | Times Cited: 96
Synthetic Lethal Interaction of SHOC2 Depletion with MEK Inhibition in RAS-Driven Cancers
Rita Sulahian, Jason J. Kwon, Katherine H. Walsh, et al.
Cell Reports (2019) Vol. 29, Iss. 1, pp. 118-134.e8
Open Access | Times Cited: 79
Unlocking the efficiency of genomics laboratories with robotic liquid-handling
Houriiyah Tegally, James Emmanuel San, Jennifer Giandhari, et al.
BMC Genomics (2020) Vol. 21, Iss. 1
Open Access | Times Cited: 70
Structure–function analysis of the SHOC2–MRAS–PP1C holophosphatase complex
Jason J. Kwon, Behnoush Hajian, Yuemin Bian, et al.
Nature (2022) Vol. 609, Iss. 7926, pp. 408-415
Open Access | Times Cited: 58
The molecular genetics of RASopathies: An update on novel disease genes and new disorders
Marco Tartaglia, Yoko Aoki, Bruce D. Gelb
American Journal of Medical Genetics Part C Seminars in Medical Genetics (2022) Vol. 190, Iss. 4, pp. 425-439
Open Access | Times Cited: 43
The small GTPase MRAS is a broken switch
Gabriela Bernal Astrain, Regina Strakhova, Chang Hwa Jo, et al.
Nature Communications (2025) Vol. 16, Iss. 1
Open Access | Times Cited: 1
SHOC2–MRAS–PP1 complex positively regulates RAF activity and contributes to Noonan syndrome pathogenesis
Lucy C. Young, Nicole Hartig, Isabel Boned del Río, et al.
Proceedings of the National Academy of Sciences (2018) Vol. 115, Iss. 45
Open Access | Times Cited: 76
Delineation of LZTR1 mutation-positive patients with Noonan syndrome and identification of LZTR1 binding to RAF1–PPP1CB complexes
Ikumi Umeki, Tetsuya Niihori, Taiki Abe, et al.
Human Genetics (2018) Vol. 138, Iss. 1, pp. 21-35
Closed Access | Times Cited: 71
SHOC2 phosphatase-dependent RAF dimerization mediates resistance to MEK inhibition in RAS-mutant cancers
Greg G. Jones, Isabel Boned del Río, Sibel Sarı, et al.
Nature Communications (2019) Vol. 10, Iss. 1
Open Access | Times Cited: 68
Intronic CRISPR Repair in a Preclinical Model of Noonan Syndrome–Associated Cardiomyopathy
Ulrich Hanses, Mandy Kleinsorge, Lennart Roos, et al.
Circulation (2020) Vol. 142, Iss. 11, pp. 1059-1076
Open Access | Times Cited: 66
Activating Mutations of RRAS2 Are a Rare Cause of Noonan Syndrome
Yline Capri, Elisabetta Flex, Oliver H.F. Krumbach, et al.
The American Journal of Human Genetics (2019) Vol. 104, Iss. 6, pp. 1223-1232
Open Access | Times Cited: 64
Structure of the SHOC2–MRAS–PP1C complex provides insights into RAF activation and Noonan syndrome
Daniel A. Bonsor, Patrick Alexander, Kelly Snead, et al.
Nature Structural & Molecular Biology (2022) Vol. 29, Iss. 10, pp. 966-977
Open Access | Times Cited: 37
Structural basis for SHOC2 modulation of RAS signalling
Nicholas P. D. Liau, Matthew C. Johnson, Saeed Izadi, et al.
Nature (2022) Vol. 609, Iss. 7926, pp. 400-407
Open Access | Times Cited: 30
Germline-Activating RRAS2 Mutations Cause Noonan Syndrome
Tetsuya Niihori, Koki Nagai, Atsushi Fujita, et al.
The American Journal of Human Genetics (2019) Vol. 104, Iss. 6, pp. 1233-1240
Open Access | Times Cited: 51
SHOC2 complex-driven RAF dimerization selectively contributes to ERK pathway dynamics
Isabel Boned del Río, Lucy C. Young, Sibel Sarı, et al.
Proceedings of the National Academy of Sciences (2019) Vol. 116, Iss. 27, pp. 13330-13339
Open Access | Times Cited: 46
The Role of R-Ras Proteins in Normal and Pathologic Migration and Morphologic Change
Shannon M. Weber, Steven L. Carroll
American Journal Of Pathology (2021) Vol. 191, Iss. 9, pp. 1499-1510
Open Access | Times Cited: 35
MRAS: A Close but Understudied Member of the RAS Family
Lucy C. Young, Pablo Rodriguez‐Viciana
Cold Spring Harbor Perspectives in Medicine (2018) Vol. 8, Iss. 12, pp. a033621-a033621
Open Access | Times Cited: 42
Activating MRAS mutations cause Noonan syndrome associated with hypertrophic cardiomyopathy
Marialetizia Motta, Lena Sagi‐Dain, Oliver H.F. Krumbach, et al.
Human Molecular Genetics (2019) Vol. 29, Iss. 11, pp. 1772-1783
Closed Access | Times Cited: 42
Page 1 - Next Page

Scroll to top